Harmony TPV EMEA PMS

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
The Harmony Transcatheter Pulmonary Valve (TPV) System is indicated for use in the management of pediatric and adult congenital heart disease patients with severe pulmonary regurgitation (i.e., severe pulmonary regurgitation as determined by echocardiography and/or pulmonary regurgitant fraction ≥ 30% as determined by cardiac magnetic resonance imaging) who have a native or surgically-repaired right ventricular outflow tract and are clinically indicated for pulmonary valve replacement as judged by the medical team.
Epistemonikos ID: 4624f333cf3af65c82deb1e8011f82cb51676518
First added on: Apr 03, 2025